Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells

BACKGROUND: Cisplatin (CDDP) is the most frequently used chemotherapeutic agent for various types of advanced cancer, including gastric cancer. However, almost all cancer cells acquire resistance against CDDP, and this phenomenon adversely affects prognosis. Thus, new chemotherapeutic agents that ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Mamoru, Kataoka, Hiromi, Yano, Shigenobu, Ohi, Hiromi, Kawamoto, Keisuke, Shibahara, Takashi, Mizoshita, Tsutomu, Mori, Yoshinori, Tanida, Satoshi, Kamiya, Takeshi, Joh, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659059/
https://www.ncbi.nlm.nih.gov/pubmed/23672493
http://dx.doi.org/10.1186/1471-2407-13-237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659059/
https://www.ncbi.nlm.nih.gov/pubmed/23672493
http://dx.doi.org/10.1186/1471-2407-13-237

Ejemplares similares